Skip to main content

Raiffeisen Bank International AG

Bank

Position in IONS — Ionis Pharmaceuticals Inc

CIK 2044885 VIENNA, C4

Position in IONS

as of Mar 31, 2026 · filed Apr 24, 2026
Position Value
$2,703,240
-$65,610 QoQ
Shares Held
36,000
+2.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IONS Over Time

Shares Held

Position Value (USD)

Derivatives in IONS

reported options exposure · as of Mar 31, 2026
CallValue
$131,707
CallShares
1,754
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Raiffeisen Bank International AG holds $97,826,369 across 28 Biotechnology names. IONS ranks #5 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 IONS
Ionis Pharmaceuticals Inc
This page
36,000 $2,703,240

All Filings in IONS

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $131,707 1,754
2026-03-31 $2,703,240 36,000
2025-12-31 $2,768,850 35,000
2025-12-31 $138,758 1,754
2025-09-30 $3,271,000 50,000
2025-09-30 $114,746 1,754
2025-06-30 $2,242,350 56,754
2025-03-31 $1,259,718 41,754
2024-12-31 $61,319 1,754